Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled date : 2021 - 07 - 20 save search
Brookfield Property Partners Obtains Final Court Approval for the Privatization Transaction and Brookfield Property REIT Announces Intention to Redeem Its 6.375% Series A Cumulative Redeemable Preferred Stock
Published: 2021-07-20 (Crawled : 22:00) - globenewswire.com
BAM | $38.32 -0.26% 0.0% 1.8M
|
Finance
|
| O: 1.04%
H: 2.94%
C: 2.58%
approval
MULTIMEDIA UPDATE - Albireo Announces FDA Approval of Bylvay™ (odevixibat), the First Drug Treatment for Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)
Published: 2021-07-20 (Crawled : 22:00) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 3.44%
H: 2.51%
C: -1.44%
media treatment fda fda approval drug approval
Flatiron Health Real-World Data Support FDA Approval of New Dosing Regimen for ERBITUX® (cetuximab)
Published: 2021-07-20 (Crawled : 16:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.37%
H: 1.17%
C: 0.01%
fda fda approval approval
Excessive Impurities Cause Recall of Pfizer's Anti-Smoking Drug
Published: 2021-07-20 (Crawled : 15:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
drug
Sorrento Announces Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab BiobetterSorrento to Exclusively Market the Product Outside of China Including US, Japan and Europe
Published: 2021-07-20 (Crawled : 14:00) - biospace.com/
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.58%
H: 1.39%
C: 0.25%
europe china approval
ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection
Published: 2021-07-20 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 2.58%
H: 0.0%
C: -0.63%
fda approval
Myovant Sciences Announces European Commission Approval for RYEQO® for the Treatment of Women With Uterine Fibroids
Published: 2021-07-20 (Crawled : 07:00) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 1.27%
H: 1.7%
C: -0.4%
treatment europe women approval
Japan Becomes First Country to Approve Regeneron Antibody Cocktail (casirivimab and imdevimab) for the Treatment of Mild to Moderate COVID-19
Published: 2021-07-20 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.29%
H: 1.02%
C: 0.78%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.52%
H: 0.92%
C: -0.18%
covid treatment antibody casirivimab
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.